There is no cure for sociopathy. The condition, clinically known as antisocial personality disorder (ASPD), involves deep-rooted patterns of behavior and brain structure differences that cannot be fully reversed with any current treatment. That said, specific symptoms like aggression, impulsivity, and difficulty maintaining relationships can improve with therapy and, in some cases, medication. The outlook is not as hopeless as it once seemed.
What Sociopathy Actually Is
“Sociopathy” is not an official diagnosis. The clinical term is antisocial personality disorder, defined in the DSM-5 as a persistent pattern of disregarding and violating the rights of others that begins before age 15 and continues into adulthood. A formal diagnosis requires at least three features from a list that includes repeated lawbreaking, deceitfulness, impulsivity, aggression, reckless disregard for safety, chronic irresponsibility, and a lack of remorse for harming others.
The diagnosis can only be made at age 18 or older, though evidence of conduct problems in childhood must be present. ASPD is more common in men than women, and personality disorders overall affect roughly 4 to 5 percent of the population worldwide, with prevalence tending to decrease with age.
Why a Cure Is So Difficult
ASPD is not just a set of bad habits. It has measurable roots in brain structure. People with the disorder show roughly 11 percent less gray matter in the prefrontal cortex compared to people without it. The prefrontal cortex is the part of the brain most responsible for impulse control, planning, and weighing consequences. Additional volume reductions appear in brain regions that handle decision-making and social judgment.
The wiring between brain areas matters too. Imaging studies reveal weakened connections in the nerve bundle that links the prefrontal cortex to the amygdala, which processes fear and emotional responses. When this connection is impaired, the prefrontal cortex has a harder time putting the brakes on impulsive or aggressive behavior. Another affected pathway connects to threat monitoring, which may explain why many people with ASPD seem unbothered by situations that would make others anxious.
These are structural differences, not temporary chemical imbalances. You cannot take a pill to grow new gray matter or rewire a neural pathway overnight. This is the core reason clinicians do not speak of “curing” ASPD. The goal instead is symptom management: reducing the behaviors that cause the most harm to the person and those around them.
Therapies That Show Some Promise
Talk therapy for ASPD has a complicated track record. A large Cochrane review of psychological treatments found that cognitive behavioral therapy (CBT) added to standard care showed no measurable difference in physical aggression or social functioning at 12 months in outpatient studies. The evidence was rated low to very low certainty, meaning the studies were small and their conclusions fragile. This doesn’t mean therapy is useless for ASPD, but it does mean the most commonly available form of talk therapy has limited proof behind it for this specific condition.
Dialectical behavior therapy (DBT), originally developed for borderline personality disorder, showed some early evidence of reducing self-harm days, though the study involved only 14 participants. The Cochrane review flagged DBT as one of a small number of approaches that may outperform standard care, but the evidence base remains thin.
The most encouraging results so far come from mentalization-based treatment (MBT), a therapy focused on helping people understand their own mental states and those of others. In a randomized controlled trial of patients who had both borderline and antisocial personality disorders, 18 months of MBT produced statistically significant improvements in overall functioning, relationship problems, and social adjustment compared to a structured alternative of similar intensity. Participants also showed reductions in anger, hostility, paranoia, self-harm, and negative mood. These results are promising, though the study specifically included people with co-occurring borderline personality disorder, so how well MBT works for ASPD alone is still an open question.
What Medication Can and Cannot Do
No medication is approved specifically for ASPD, and no pill addresses the core personality features. What medications can do is take the edge off certain dangerous symptoms, particularly impulsive aggression. Anticonvulsants like carbamazepine and sodium valproate have been reported to improve impulse control and reduce aggressive outbursts. One study in male prisoners found that phenytoin, another anticonvulsant, reduced the frequency and intensity of impulsive (though not premeditated) aggression compared to placebo. Lithium has also shown some benefit for behavioral dyscontrol.
Antidepressants in the SSRI class have been used to reduce aggressive and impulsive behavior as well, though the evidence comes largely from case reports and small studies rather than large trials. In practice, medication for ASPD is prescribed to manage crises and reduce harm, not to treat the disorder itself. It is one tool among several, and it works best when combined with some form of structured therapy.
Symptoms Often Ease With Age
One of the more hopeful aspects of ASPD is that its most destructive features, particularly impulsivity and aggression, tend to decline naturally as people move into their 40s and beyond. This is sometimes called “burnout,” and while the term sounds informal, the pattern is well documented. Population studies consistently show that personality disorder prevalence drops with age.
This does not mean the disorder disappears. Core traits like low empathy and manipulativeness may persist. But the reckless, aggressive behaviors that lead to arrests, job losses, and damaged relationships often soften over time, even without formal treatment. The reasons likely involve a combination of age-related changes in brain chemistry, accumulated consequences that shape behavior, and the natural slowing of sensation-seeking drives.
What Improvement Looks Like
Because there is no cure, “success” with ASPD looks different than it does for conditions like depression or anxiety. Improvement means fewer aggressive incidents, more stable employment, less contact with the criminal justice system, and better (if still imperfect) relationships. It means managing the disorder rather than eliminating it.
Treatment works best when someone is genuinely motivated to change their behavior, which is one of ASPD’s central challenges. Many people with the disorder do not see their behavior as a problem, or they enter treatment only because a court ordered it. Therapies like MBT that focus on helping people understand the perspectives of others may partly address this barrier, but progress is typically slow and requires sustained engagement over months or years.
The honest answer is that ASPD remains one of the most difficult personality disorders to treat. No therapy or medication can fully resolve it. But the combination of structured psychological treatment, targeted medication for the most dangerous symptoms, and the natural mellowing that comes with age means that many people with the disorder do end up causing less harm, to themselves and others, than they did in their younger years.